Integral Derivatives’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$526K Sell
6,800
-10,800
-61% -$869K 0.01% 371
2017
Q4
$1.49M Buy
17,600
+6,200
+54% +$528K 0.03% 372
2017
Q3
$975K Sell
11,400
-5,600
-33% -$459K 0.02% 502
2017
Q2
$1.4M Sell
17,000
-8,100
-32% -$661K 0.03% 389
2017
Q1
$2.11M Buy
25,100
+5,300
+27% +$425K 0.04% 296
2016
Q4
$1.46M Sell
19,800
-13,900
-41% -$1.04M 0.03% 405
2016
Q3
$2.71M Buy
+33,700
New +$2.7M 0.06% 206
2016
Q2
Sell
-3,500
Closed -$252K 1035
2016
Q1
$252K Buy
+3,500
New +$265K 0.01% 687
2015
Q3
Sell
-2,700
Closed -$225K 1188
2015
Q2
$225K Sell
2,700
-11,000
-80% -$838K 0.01% 944
2015
Q1
$995K Buy
13,700
+6,200
+83% +$441K 0.02% 511
2014
Q4
$517K Sell
7,500
-8,100
-52% -$547K 0.01% 910
2014
Q3
$1.01M Buy
+15,600
New +$988K 0.02% 706
2014
Q1
Sell
-23,900
Closed -$1.22M 1472
2013
Q4
$1.22M Buy
+23,900
New +$1.2M 0.02% 708

Other funds holding LLY

Integral Derivatives's LLY Position: Q3 2016 in Review

Integral Derivatives sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 10,675 shares — an estimated $854K sold.

Integral Derivatives first reported a position in LLY in Q1 2014 and held it in 5 quarters. The position peaked at $1.99M in Q3 2014. 1,176 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Integral Derivatives reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 10,675 Eli Lilly shares in Q3 2016, an estimated $854K.
  • Integral Derivatives first reported a position in Eli Lilly in Q1 2014 and held it in 5 quarters.
  • Integral Derivatives's Eli Lilly position peaked at $1.99M in Q3 2014.
  • 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.